Log In
Print
BCIQ
Print
Print this Print this
 

Pristiq, desvenlafaxine (DVS-233)

Also known as: desvenlafaxine extended release

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionSerotonin and norepinephrine reuptake inhibitor
Molecular Target Serotonin (5-HT) receptor ; Norepinephrine transporter
Mechanism of ActionNorepinephrine reuptake inhibitor; Serotonin (5-HT) reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationDepression
Indication DetailsPrevent depressive relapse in adult outpatients with major depressive disorder (MDD); Treat major depressive disorder (MDD); Treat major depressive disorder (MDD) in children
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today